查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
核酸治療 CDMO 市場，按產品類型、服務、按應用、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1408890

核酸治療 CDMO 市場，按產品類型、服務、按應用、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Nucleic Acid Therapeutics CDMO Market, By Product Type, By Service, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年核酸治療 CDMO 市場規模為 117.563 億美元，2023 年至 2030 年複合CAGR為 10.3%。

核酸治療CDMO市場-市場動態

核酸療法的進步、複雜的製造程序以及增加的投資來推動市場需求

該市場主要受到核酸療法的進步、複雜的製造程序和增加的投資的引導。此外，監管部門對核酸療法的批准不斷增加，以及全球對個人化醫療需求的成長，將推動對具有成本效益的 CDMO 服務的需求，從而推動市場擴張。核酸治療根據個人的基因組成提供個人化的醫療保健。隨著對精準醫療和標靶治療的需求不斷增加，這些CDMO 成為製藥和生物最終用戶公司的重要合作夥伴，旨在發揮核酸藥物的潛力。他們致力於維護嚴格的品質標準，克服監管複雜性，並採用最先進的技術促進了這些複雜分子的高效和可規模化生產。因此，這推動了基於核酸的變革療法的進步和可及性，滿足了廣泛的醫療需求。

核酸治療 CDMO 市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球市場在預測期內（2023-2030 年）每年將以 10.3% 左右的CAGR成長
  • 根據產品類型細分，預計基於 RNA 的療法將在 2022 年顯示最大的市場佔有率
  • 從服務細分來看，2022年製造業服務業為主導類型
  • 從應用細分來看，腫瘤學是2022年的主導類型
  • 按地區分類，北美是 2022 年的主要收入來源

核酸治療 CDMO 市場-細分分析：

  • 全球核酸治療 CDMO 市場根據產品類型、服務、應用、最終用戶和地區進行細分。
  • 根據產品類型，市場分為兩類：基因療法和基於RNA的療法。 2022年，以RNA為基礎的療法領域成為全球市場的主導力量。 ClinicalTrials.gov資料顯示，超過 3,500 項正在進行的臨床試驗涉及針對不同疾病的 RNA 療法。最近試驗的令人鼓舞的結果強調了基於 RNA 的藥物在治療各種疾病方面的巨大潛力，預計將推動這一領域的成長。
  • 市場根據服務分為四類：製程開發和最佳化、製造服務、分析和品質控制服務及其他。到 2022 年，製造服務類別將佔據重要的收入佔有率。基於核酸的療法（包括 RNA 和基因療法）需要製造方面的專業知識和專業知識。專門專注於核酸製造的 CDMO 對這些療法有了深入的了解，從而賦予了它們競爭優勢。在核酸治療 CDMO 市場中，服務進一步細分為製程開發和最佳化、製造服務、分析和品質控制服務等。

核酸治療 CDMO 市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

核酸治療CDMO市場-競爭格局：

在核酸合約開發和製造組織 (CDMO) 的動態領域內，公司透過採用多方面的方法來策略性地引導產業。這些實體透過重點關注 mRNA、siRNA、基因編輯或寡核苷酸合成片段來優先考慮專業化。透過完善這些專業領域的專業知識，CDMO 可以根據客戶的具體要求提供客製化解決方案和最佳化服務。同時，他們強調對最先進的最終用戶和基礎設施進行大量投資，確保他們的設施配備了核酸製造流程的最新進展。合規性仍然是其營運的一個基本方面，並嚴格關注滿足和超過 FDA 或 EMA 等機構制定的監管標準。此外，他們的服務強調靈活性和可擴展性，從而實現適應性強的製造解決方案，以適應不同的項目規模和規格。這種適應性有助於靈活地響應製藥和生物最終用戶合作夥伴不斷變化的需求，從而鞏固他們在競爭市場中的地位。

最近的發展：

2023 年 4 月，Exothera 與 Quantoom Biosciences 合作，利用 Quantoom 的創新 Nfinity 最終用戶－專為 RNA 打造的尖端連續生產平台。這項合作關係使 Exothera 成為全球領先的合約開發和製造組織 (CDMO)，為連續 RNA 生產提供現成的服務，擴大其在 RNA 製造領域的專業知識。

目錄

第 1 章：核酸治療 CDMO 市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的核酸治療 CDMO 市場片段
    • 核酸治療 CDMO 市場片段（依服務）
    • 核酸治療 CDMO 市場片段（依應用）
    • 最終用戶的核酸治療 CDMO 市場片段
    • 按國家/地區分類的核酸治療 CDMO 市場片段
    • 按地區分類的核酸治療 CDMO 市場片段
  • 競爭洞察

第 3 章：核酸治療 CDMO 主要市場趨勢

  • 核酸治療 CDMO 市場促進因素
    • 市場促進因素的影響分析
  • 核酸治療 CDMO 市場限制
    • 市場限制影響分析
  • 核酸治療 CDMO 市場機會
  • 核酸治療CDMO市場未來趨勢

第 4 章：核酸治療 CDMO 產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：核酸治療 CDMO 市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：核酸治療 CDMO 市場格局

  • 2022 年核酸治療 CDMO 市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：核酸治療 CDMO 市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 基因治療
    • 基於RNA的療法

第 8 章：核酸治療 CDMO 市場 - 按服務

  • 概述
    • 按服務分類的細分市場佔有率分析
    • 製程開發與最佳化
    • 製造服務
    • 分析和品質控制服務
    • 其他

第 9 章：核酸治療 CDMO 市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 腫瘤學
    • 遺傳性疾病
    • 傳染性疾病
    • 其他

第 10 章：核酸治療 CDMO 市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥公司
    • 政府及學術研究機構
    • 生技公司

第 11 章：核酸治療 CDMO 市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美核酸治療CDMO主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按服務）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲核酸治療CDMO主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按服務）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區核酸治療CDMO主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按服務）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲核酸治療CDMO主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按服務）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲核酸治療CDMO主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按服務）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 核酸治療 CDMO 產業

  • 競爭儀表板
  • 公司簡介
    • Catalent
    • Thermo Fisher Scientific
    • Lonza
    • FUJIFILM Diosynth Biotechnologies
    • Cognate BioServices
    • Eurofins Genomics
    • Sirion Biotech
    • Oxford Biomedica
    • Danaher (Aldevron)
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2052

REPORT HIGHLIGHT

Nucleic Acid Therapeutics CDMO Market size was valued at USD 11,756.3 Million in 2022, expanding at a CAGR of 10.3% from 2023 to 2030.

Nucleic acid Contract Development and Manufacturing Organizations (CDMOs) hold a critical position in the ever-changing realm of pharmaceutical advancements. Their specialized proficiency in developing, manufacturing, and producing nucleic acid-based therapeutics, such as mRNA, siRNA, gene therapies, and oligonucleotides, underscores their importance in turning innovative research into practical treatments.

Nucleic Acid Therapeutics CDMO Market- Market Dynamics

Advancements in nucleic acid therapeutics, intricate manufacturing procedures, and heightened investments to propel market demand

The market is primarily steered by advancements in nucleic acid therapeutics, intricate manufacturing procedures, and heightened investments. Additionally, the increasing regulatory approvals for nucleic acid therapeutics and the global rise in demand for personalized medicine are poised to drive the need for cost-effective CDMO services, consequently propelling market expansion. Nucleic acid treatments offer personalized healthcare by tailoring to an individual's genetic makeup. With the escalating demand for precision medicine and targeted therapies, these CDMOs emerge as vital partners for pharmaceutical and bioEnd User firms aiming to leverage the potential of nucleic acid-based medications.Their commitment to upholding rigorous quality standards, navigating through regulatory complexities, and employing state-of-the-art technologies facilitates efficient and scalable production of these intricate molecules. Consequently, this drives advancements and accessibility to transformative nucleic acid-based therapies, addressing a wide array of medical necessities.

Nucleic Acid Therapeutics CDMO Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.3% over the forecast period (2023-2030)
  • Based on product type segmentation, RNA-based therapies was predicted to show maximum market share in the year 2022
  • Based on Service segmentation, manufacturing services was the leading type in 2022
  • Based on Application segmentation, Oncology was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Nucleic Acid Therapeutics CDMO Market- Segmentation Analysis:

  • The Global Nucleic Acid Therapeutics CDMO Market is segmented on the basis of Product Type, Service, Application, End User, and Region.
  • The market is divided into two categories based on product type: Gene Therapy and RNA-based Therapies. In 2022, the RNA-based therapies sector emerged as the dominant force in the global market. ClinicalTrials.gov data revealed over 3,500 ongoing clinical trials involving RNA therapies for diverse diseases. Encouraging results from recent trials underscore the substantial potential of RNA-based medications in addressing various illnesses, anticipated to propel the growth of this segment.
  • The market is divided into four categories based on Service: Process Development and Optimization, Manufacturing Services, Analytical and Quality Control Services and Others. The manufacturing services category commanded a significant revenue share in 2022. Nucleic acid-based therapies, encompassing RNA and gene therapies, demand specialized knowledge and expertise in manufacturing. CDMOs exclusively focused on nucleic acid manufacturing have cultivated an in-depth understanding of these therapies, granting them a competitive edge. Within the nucleic acid therapeutics CDMO market, services are further segmented into process development and optimization, manufacturing services, analytical and quality control services, and others.

Nucleic Acid Therapeutics CDMO Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Nucleic Acid Therapeutics CDMO Market- Competitive Landscape:

Within the dynamic sphere of nucleic acid Contract Development and Manufacturing Organizations (CDMOs), companies navigate the industry strategically by adopting multifaceted approaches. These entities prioritize specialization by focusing efforts on mRNA, siRNA, gene editing, or oligonucleotide synthesis segments. By refining expertise in these specialized domains, CDMOs offer customized solutions and optimized services tailored to their clients' specific requirements. Concurrently, they emphasize substantial investments in state-of-the-art End User and infrastructure, ensuring their facilities are equipped with the latest advancements in nucleic acid manufacturing processes. Compliance remains a fundamental aspect of their operations, with stringent attention on meeting and exceeding regulatory standards set by bodies like the FDA or EMA. Moreover, flexibility and scalability are emphasized in their services, enabling adaptable manufacturing solutions accommodating diverse project sizes and specifications. This adaptability facilitates agility in response to the evolving needs of pharmaceutical and bioEnd User partners, consolidating their position in the competitive market.

Recent Developments:

In April 2023, Exothera collaborated with Quantoom Biosciences to leverage Quantoom's innovative Nfinity End User-a cutting-edge continuous production platform crafted for RNA. This partnership positions Exothera as the pioneering Contract Development and Manufacturing Organization (CDMO) globally to offer an off-the-shelf service for continuous RNA production, expanding its expertise in the RNA manufacturing domain.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET KEY PLAYERS

  • Catalent
  • Thermo Fisher Scientific
  • Lonza
  • FUJIFILM Diosynth Biotechnologies
  • Cognate BioServices
  • Eurofins Genomics
  • Sirion Biotech
  • Oxford Biomedica
  • Danaher (Aldevron)
  • Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY PRODUCT TYPE

  • Gene Therapy
  • RNA-based Therapies

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY SERVICE

  • Process Development and Optimization
  • Manufacturing Services
  • Analytical and Quality Control Services
  • Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY APPLICATION

  • Oncology
  • Genetic Disorders
  • Infectious Diseases
  • Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY END USER

  • Pharmaceutical Companies
  • Government & Academic Research Institutes
  • Biotech Companies

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nucleic Acid Therapeutics CDMO Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nucleic Acid Therapeutics CDMO Market Snippet by Product Type
    • 2.1.2. Nucleic Acid Therapeutics CDMO Market Snippet by Service
    • 2.1.3. Nucleic Acid Therapeutics CDMO Market Snippet by Application
    • 2.1.4. Nucleic Acid Therapeutics CDMO Market Snippet by End User
    • 2.1.5. Nucleic Acid Therapeutics CDMO Market Snippet by Country
    • 2.1.6. Nucleic Acid Therapeutics CDMO Market Snippet by Region
  • 2.2. Competitive Insights

3. Nucleic Acid Therapeutics CDMO Key Market Trends

  • 3.1. Nucleic Acid Therapeutics CDMO Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nucleic Acid Therapeutics CDMO Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nucleic Acid Therapeutics CDMO Market Opportunities
  • 3.4. Nucleic Acid Therapeutics CDMO Market Future Trends

4. Nucleic Acid Therapeutics CDMO Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nucleic Acid Therapeutics CDMO Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Nucleic Acid Therapeutics CDMO Market Landscape

  • 6.1. Nucleic Acid Therapeutics CDMO Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nucleic Acid Therapeutics CDMO Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Gene Therapy
    • 7.1.3. RNA-based Therapies

8. Nucleic Acid Therapeutics CDMO Market - By Service

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Service, 2022 & 2030 (%)
    • 8.1.2. Process Development and Optimization
    • 8.1.3. Manufacturing Services
    • 8.1.4. Analytical and Quality Control Services
    • 8.1.5. Others

9. Nucleic Acid Therapeutics CDMO Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Oncology
    • 9.1.3. Genetic Disorders
    • 9.1.4. Infectious Diseases
    • 9.1.5. Others

10. Nucleic Acid Therapeutics CDMO Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Government & Academic Research Institutes
    • 10.1.4. Biotech Companies

11. Nucleic Acid Therapeutics CDMO Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Nucleic Acid Therapeutics CDMO Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Catalent
    • 12.2.2. Thermo Fisher Scientific
    • 12.2.3. Lonza
    • 12.2.4. FUJIFILM Diosynth Biotechnologies
    • 12.2.5. Cognate BioServices
    • 12.2.6. Eurofins Genomics
    • 12.2.7. Sirion Biotech
    • 12.2.8. Oxford Biomedica
    • 12.2.9. Danaher (Aldevron)
    • 12.2.10. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nucleic Acid Therapeutics CDMO Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by Product Type 2018-2030 (USD Million)
  • TABLE Nucleic Acid Therapeutics CDMO Market: Service Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Service
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by Service 2018-2030 (USD Million)
  • TABLE Nucleic Acid Therapeutics CDMO Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by Application 2018-2030 (USD Million)
  • TABLE Nucleic Acid Therapeutics CDMO Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by End User 2018-2030 (USD Million)
  • TABLE Nucleic Acid Therapeutics CDMO Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by Region 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Nucleic Acid Therapeutics CDMO Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Service segment market share analysis, 2022 & 2030
  • FIGURE Service segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE Europe Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE Asia Pacific Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE Latin America Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE Middle East and Africa Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Nucleic Acid Therapeutics CDMO Market share analysis by country, 2022
  • FIGURE Germany Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Nucleic Acid Therapeutics CDMO Market share analysis by country, 2022
  • FIGURE India Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Nucleic Acid Therapeutics CDMO Market share analysis by country, 2022
  • FIGURE Brazil Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Nucleic Acid Therapeutics CDMO Market share analysis by country, 2022
  • FIGURE Saudi Arabia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)